Global Healthcare Innovation Center Launches 'Medical Leadership Innovation Program' – Prospectus Filed

To promote the interdisciplinary and industrial integration of medicine, facilitate in-depth exploration and understanding of medicine by enterprises, investors, and multidisciplinary professionals, and jointly drive innovation in the medical industry, this initiative is guided by the Beijing Tsinghua Industrial R&D Institute, led by the Global Health Industry Innovation Center of Tsinghua Industrial R&D Institute, and supported by China Construction Bank Beijing Branch and CCB Training Center (Beijing).“Healthcare Industry Innovation Leadership Program” – Providing leaders in the medical innovation sector with comprehensive and accelerated opportunities to study medicine, while understanding it from the perspectives of medical innovation and translation.

“The Pilot Program” will commence on October 29, 2022,This program invites experts from top-tier (Grade 3A) hospitals in Beijing, specializing in clinical practice, scientific research, and medical-engineering translation. The curriculum focuses on the theory and practice, diagnosis, and treatment of cardiovascular diseases, neurology, gastroenterology, respiratory medicine, hematology, and orthopedics. To help participants gain a deeper understanding of medicine, the program incorporates supportive modules that provide a comprehensive analysis of the entire industry chain, including global healthcare trends, breakthroughs in medical innovation, interdisciplinary medical-engineering translation, financial and capital support, and upstream-downstream industrial integration. To offer members firsthand experience of real-world medical settings, the program includes practical components such as hands-on medical training and the “Into Medical Innovation” corporate visit module.

● General Practice, Systems Approach — Elite Faculty, Integrating Theory and Practice

The curriculum integrates the medical education frameworks of leading global medical institutions, with over 60 renowned experts from Beijing’s top-tier (Grade 3A) hospitals delivering specialized knowledge in an accessible manner. This approach equips participants with essential knowledge in medical diagnosis and treatment while cultivating professional medical analytical reasoning.

● Professional and Practical—Classic Content, Multidimensional Format

The course content is organized by organ systems, covering dimensions such as basic medicine, clinical diagnosis and treatment, and hands-on clinical practice. It encompasses topics including pathogenesis, clinical diagnosis and therapy, and emerging interdisciplinary frontier technologies—through “in-person lectures, case analysis, and practical training.”

● “Industry-Academia-Research” Dialogue – Deepening Resources, Cross-Boundary Collaboration

The project encompasses multidisciplinary intersections in medicine, integrating medical science, engineering, and translational research to establish a platform for exchange and collaboration, thereby creating a new model of innovation and translation for members and mentors.

● Immersive Medical Experience — Practical Drills for Applied Learning

Establish practical medical teaching modules, guiding members in the operation of advanced medical devices, interpretation of biochemical data and imaging metrics, and simulation of cutting-edge techniques in coronary artery intervention.

● Medical Innovation Ecosystem Tour—Corporate Visits to Pool Wisdom and Synergize Efforts

Lead members to visit benchmark enterprises at the forefront of medical device technology innovation, large international healthcare corporations, and medical innovation R&D centers, providing on-site observation of the operational processes of pharmaceutical and healthcare companies.

For those who wish to systematically study medical expertise and focus on cutting-edge medical technologies and their translation:

A total of 50 participants will be recruited.

The mentorship team comprises over 60 experts spanning the entire medical-engineering translation industry chain, including medical specialists from multiple Grade A tertiary hospitals across Beijing, experts in medical innovation and commercialization, academic researchers from universities and institutes, and investors with extensive experience in the healthcare sector.

● Fundamentals of Medicine and Clinical Diagnosis and Treatment
Fundamentals and Disease Diagnosis and Treatment of the Cardiovascular, Nervous, Respiratory, Digestive, Hematologic, Sensory, Urinary, and Endocrine Systems.

● Medical-Engineering Translation and Global Innovation
Interdisciplinary Integration of Medicine and Engineering, Characteristics of Global Innovation, China’s Innovation Advantages, Technological Iteration of Medical Devices, Registration, Submission, Clinical Trial Protocol Design, etc.

● Visit to the Medical Innovation Ecosystem
GE Healthcare, Boston Scientific, PINS Medical, Global Health Drug Discovery Institute, Beijing Medical Robot Industry Innovation Center, Cell and Gene Therapy Center, etc.

● Clinical Practice and Technological Breakthroughs
Innovative technologies in cardiovascular intervention, surgical robots, OCT imaging, biochemical data interpretation, and image analysis.

Project Duration:October 29, 2022 (subject to the admission notice), one-year program, once a month, two days per session.

Venue:Global Health Industry Innovation Center of Tsinghua University Institute of Industrial Research, practical teaching visit enterprises, etc.

Instruction Format:Intensive lectures and group-based exploratory research, with a focus on medical theory and clinical practice. Deepen the understanding of medicine through frontier technologies, translational coursework and practice, and visits to innovative enterprises.

● Successfully completed the program and received the Certificate of Completion for the Global Health Industry Innovation Center Leadership Program;
● Awarded the title of “Talent for Innovative Development in Medicine within the Global Health Industry” upon completion;
● Systematically understand medical theory and practice by studying medical diagnostics, treatments, and cutting-edge technologies;
● Gain insights into the key aspects of medical innovation translation by interviewing leading figures in innovation commercialization and visiting innovative enterprises;
● Become a platform partner to share resources in medicine, engineering, innovation, translation, and management practices.

01 Online Application (First Round of Material Review)

Registration Period: September 26, 2022 - October 9, 2022

Registration QR Code:

02 Candidate Interview (First Round)

Interview Date: October 10, 2022

Shortlisted candidates will be interviewed online or in person.

03 Candidate Interview (Second Round)

Interview Date: October 20, 2022

Shortlisted candidates will be interviewed online or in person.

04 Release of the Preliminary Admission List

Publication Date: October 25, 2022

Email and telephone notifications.

05 Issuance of Admission Letters

Issue Date: October 27, 2022

The Center will mail the admission notice and enrollment instructions.

06 Member Check-in

Registration Date: October 29, 2022

Members must report on time.

Students may apply for full-tuition, half-tuition, and merit-based scholarships. For inquiries regarding tuition fees and scholarship policies, please contact us.

Registration QR Code:

Inquiry Email:linghang@ghic.cn

Inquiry Hotline:

Registration Hotline: 010-62951590

Teacher Yang: 18801128705

Teacher Chang: 18210617099

GHIC Global Official Website:www.ghic.cn

Global Healthcare Innovation Center (hereinafter referred to as “GHIC”), initiated and established by the Beijing Tsinghua Industrial R&D Institute (hereinafter referred to as “Tsinghua IRI”), aims to connect global medical innovation technologies and resources, strengthen the commercialization of scientific and technological achievements, facilitate the effective implementation and development of innovative technologies in medical devices, diagnostics, and services, and provide comprehensive support for early- to mid-stage projects.

GHIC focuses on hard-tech healthcare projects, spanning fields such as therapeutics, diagnostics, testing, rehabilitation, artificial intelligence, medical robotics, chips, and medical materials. It has been successively recognized as the Zhongguancun Hard-Tech Incubation Platform, a Technology Service Platform of the Zhongguancun Demonstration Zone (Technology Transfer Services), and a Beijing Municipal Enterprise Incubator for Science and Technology Enterprises.

GHIC provides full-lifecycle services for medical-engineering translation to resident enterprises, helping innovative companies bridge clinical needs, conduct key technology research and develop core products through technical collaborations, thereby discovering and creating core products that drive industry advancement. Leveraging Tsinghua University’s strengths in fundamental engineering research, as well as its international resources and global influence, GHIC aggregates high-quality resources from top domestic and overseas research institutions, leading universities and colleges, clinical hospitals, and industry alliances. Centered on four major platforms—namely, the R&D Support Platform, the Innovative Project Discovery Platform, the Project Translation Platform, and the Collaborative Innovation Empowerment Platform—GHIC delivers end-to-end services for projects.